Perioperative Anesthesia Management: The Role of MicroRNAs

Masashi Ishikawa1

  • 1Department of Anesthesiology and Pain Medicine, Graduate School of Medicine, Nippon Medical School.

Insights

Anesthetics alter microRNA (miRNA) expression in organs, impacting cardiovascular disease and cancer. Understanding these changes is crucial for future perioperative drug selection and targeted therapies.

Area of Science:

  • Molecular Biology
  • Anesthesiology
  • Genomics

Background:

  • MicroRNAs (miRNAs) are non-coding RNA molecules with regulatory roles.
  • Organ- and disease-specific miRNAs show potential as diagnostic and therapeutic targets, especially for cardiovascular disease and cancer.
  • The impact of anesthetics and perioperative management on miRNA expression is not fully understood.

Purpose of the Study:

  • To review the effects of anesthesia management on miRNA expression.
  • To explore how different anesthetics influence miRNA expression across various organs.
  • To discuss the implications of these changes for perioperative medicine, cardiovascular disease, and cancer treatment.

Main Methods:

  • Review of existing literature on anesthesia and miRNA expression.
  • Analysis of studies investigating anesthetic-induced changes in miRNA expression in the brain, lungs, and liver.
  • Examination of the complex interactions between miRNAs, mRNA, and cellular activity.

Main Results:

  • Anesthetics, such as sevoflurane, induce organ-specific gene expression patterns.
  • Changes in miRNA expression vary significantly depending on the anesthetic drug and the affected organ.
  • Propofol may suppress cancer cells via intercellular communication, while inhalational anesthetics have varied effects on cancer cell activity.

Conclusions:

  • Anesthetic management significantly influences miRNA expression, with complex, drug- and organ-specific alterations.
  • miRNAs play a role in the interplay between perioperative management, cardiovascular disease, and cancer.
  • Future perioperative drug selection and administration will likely consider miRNA expression profiles.